EC
VTAE

EcoR1 Capital’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

EcoR1 Capital’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-207,000
Closed -$3.44M – 28
2014
Q4 		$3.44M Buy
+207,000
New +$3.03M 1.74% 16

Other funds holding VTAE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EcoR1 Capital's VTAE Position: Q1 2015 in Review

EcoR1 Capital sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q1 2015, closing a stake of 207,000 shares — an estimated $3.44M sold.

EcoR1 Capital first reported a position in VTAE in Q4 2014 and held it in 1 quarter. The position peaked at $3.44M in Q4 2014. 52 funds tracked by Wall St. Rank hold VTAE as of Q1 2015.

  • EcoR1 Capital reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q1 2015 after selling out during the quarter.
  • EcoR1 Capital sold 207,000 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q1 2015, an estimated $3.44M.
  • EcoR1 Capital first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 1 quarter.
  • EcoR1 Capital's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $3.44M in Q4 2014.
  • 52 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q1 2015.

Based on EcoR1 Capital's 13F filing for Q1 2015, filed 15 May 2015.